(firstQuint)Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer.

 This study is a Phase 2, single arm study of KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.

 PSA response is the primary end-point and objective responses will be checked as available.

.

 Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer@highlight

The purpose of this trial is to study KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.

